Finance   Jun    Decline  High opportunity   

General search term.
Might be referring to: (the “Company”; NASDAQ/TASE: KTOV) is a clinical-stage company focusing on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, to create successful long-lasting treatments for people with cancer.Dec 10, 2020.
This is a seasonal trend that repeats every June.
This trend is forecasted to be growing in the next 2 years.